Harvest Capital Strategies Has Lowered Green Plains (GPRE) Holding By $8.40 Million; Seattle Genetics, Inc. (SGEN) Had 6 Bullish Analysts

October 12, 2017 - By Linda Rogers

Harvest Capital Strategies Llc decreased Green Plains Inc (GPRE) stake by 43.75% reported in 2017Q2 SEC filing. Harvest Capital Strategies Llc sold 420,000 shares as Green Plains Inc (GPRE)’s stock declined 5.88%. The Harvest Capital Strategies Llc holds 540,000 shares with $11.10 million value, down from 960,000 last quarter. Green Plains Inc now has $808.94 million valuation. The stock declined 1.27% or $0.25 reaching $19.5 per share. About 48,790 shares traded. Green Plains Inc (NASDAQ:GPRE) has risen 33.17% since October 12, 2016 and is uptrending. It has outperformed by 16.47% the S&P500.

Among 16 analysts covering Seattle Genetics (NASDAQ:SGEN), 6 have Buy rating, 1 Sell and 9 Hold. Therefore 38% are positive. Seattle Genetics had 45 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, July 31 by RBC Capital Markets. The stock has “Buy” rating by Jefferies on Monday, June 12. The company was maintained on Wednesday, August 16 by Oppenheimer. Barclays Capital downgraded the stock to “Equal-Weight” rating in Tuesday, November 29 report. The firm earned “Buy” rating on Monday, June 19 by H.C. Wainwright. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Hold” rating by Cantor Fitzgerald on Wednesday, July 27. The stock has “Hold” rating by Oppenheimer on Monday, July 24. Barclays Capital initiated the shares of SGEN in report on Thursday, February 4 with “Overweight” rating. RBC Capital Markets maintained Seattle Genetics, Inc. (NASDAQ:SGEN) rating on Tuesday, December 6. RBC Capital Markets has “Outperform” rating and $72 target. The firm earned “Outperform” rating on Monday, October 10 by RBC Capital Markets. See Seattle Genetics, Inc. (NASDAQ:SGEN) latest ratings:

10/10/2017 Broker: Oppenheimer Rating: Hold Initiate
03/10/2017 Broker: SunTrust Rating: Hold New Target: $45.0 Maintain
15/09/2017 Broker: Needham Rating: Buy New Target: $72.0 Maintain
15/09/2017 Broker: RBC Capital Markets Rating: Outperform New Target: $58 Initiates Coverage On
12/09/2017 Broker: Jefferies Rating: Buy New Target: $53.0 Maintain
29/08/2017 Broker: Cantor Fitzgerald Rating: Hold Maintain
29/08/2017 Broker: Oppenheimer Rating: Hold Maintain
16/08/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $46.0 Maintain
16/08/2017 Broker: Oppenheimer Rating: Hold Maintain
27/07/2017 Broker: Cowen & Co Rating: Hold New Target: $54.0000 Maintain

Investors sentiment decreased to 1.3 in 2017 Q2. Its down 0.20, from 1.5 in 2017Q1. It dropped, as 30 investors sold Seattle Genetics, Inc. shares while 75 reduced holdings. 48 funds opened positions while 89 raised stakes. 137.48 million shares or 0.82% less from 138.62 million shares in 2017Q1 were reported. Hbk Limited Partnership accumulated 21,500 shares or 0.01% of the stock. Quantbot Technology Limited Partnership holds 0.01% or 1,226 shares in its portfolio. Pub Employees Retirement Association Of Colorado accumulated 0.01% or 20,370 shares. Dimensional Fund Advsr Limited Partnership holds 204,302 shares. 32,000 are held by Platinum Investment Management. Mitsubishi Ufj stated it has 1.01M shares or 0.1% of all its holdings. Moreover, Comerica Bancshares has 0% invested in Seattle Genetics, Inc. (NASDAQ:SGEN). Cap Int Ca holds 0.66% or 193,515 shares. Morgan Stanley reported 0.01% stake. Verity Asset Management accumulated 5,882 shares or 0.23% of the stock. 95,500 are held by Sarl. Ecor1 Limited Liability Company has 0.14% invested in Seattle Genetics, Inc. (NASDAQ:SGEN). Canada Pension Plan Investment Board invested 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN). Td Asset stated it has 36,471 shares. Wasatch Advisors, Utah-based fund reported 1.06 million shares.

About 352,468 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since October 12, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.

Since May 5, 2017, it had 0 insider buys, and 3 insider sales for $2.20 million activity. The insider SIEGALL CLAY B sold 10,423 shares worth $679,698. On Wednesday, May 31 HIMES VAUGHN B sold $625,922 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) or 10,000 shares.

Seattle Genetics, Inc. is a biotechnology firm focused on the development and commercialization of therapies for the treatment of cancer. The company has market cap of $8.72 billion. The Firm is engaged in the development and sale of pharmaceutical products on its own behalf or in collaboration with others. It currently has negative earnings. The Company’s marketed product ADCETRIS, or brentuximab vedotin, is an antibody-drug conjugate .

Harvest Capital Strategies Llc increased Post Holdings Inc (NYSE:POST) stake by 5,000 shares to 76,000 valued at $5.90M in 2017Q2. It also upped Everbridge Inc stake by 50,000 shares and now owns 400,000 shares. Agrium Inc (NYSE:AGU) was raised too.

Among 14 analysts covering Green Plains Renewable Energy (NASDAQ:GPRE), 12 have Buy rating, 0 Sell and 2 Hold. Therefore 86% are positive. Green Plains Renewable Energy had 24 analyst reports since July 21, 2015 according to SRatingsIntel. As per Monday, November 2, the company rating was maintained by Roth Capital. The company was initiated on Tuesday, July 21 by Robert W. Baird. The company was maintained on Wednesday, November 18 by Credit Suisse. Jefferies maintained it with “Buy” rating and $3200 target in Thursday, June 15 report. As per Tuesday, July 21, the company rating was initiated by Stifel Nicolaus. On Tuesday, July 21 the stock rating was initiated by Credit Suisse with “Outperform”. Jefferies maintained Green Plains Inc (NASDAQ:GPRE) on Friday, September 15 with “Buy” rating. On Tuesday, July 21 the stock rating was initiated by Macquarie Research with “Neutral”. BB&T Capital initiated Green Plains Inc (NASDAQ:GPRE) on Thursday, November 19 with “Buy” rating. The rating was initiated by Barclays Capital on Tuesday, July 21 with “Overweight”.

Investors sentiment increased to 1.06 in 2017 Q2. Its up 0.21, from 0.85 in 2017Q1. It improved, as 31 investors sold GPRE shares while 41 reduced holdings. 26 funds opened positions while 50 raised stakes. 41.99 million shares or 3.75% more from 40.47 million shares in 2017Q1 were reported. Bluecrest Capital Limited reported 26,139 shares. California Public Employees Retirement Sys accumulated 0.01% or 218,700 shares. Kennedy Capital holds 0.1% or 253,417 shares. Hbk Lp reported 0.02% in Green Plains Inc (NASDAQ:GPRE). Northern has 0.01% invested in Green Plains Inc (NASDAQ:GPRE). Moreover, Da Davidson & has 0% invested in Green Plains Inc (NASDAQ:GPRE). The Michigan-based Plante Moran Limited Com has invested 0% in Green Plains Inc (NASDAQ:GPRE). Bessemer Group holds 414,200 shares. Shell Asset Mgmt Com has 0% invested in Green Plains Inc (NASDAQ:GPRE) for 3,401 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% stake. Bancorporation Of Nova Scotia reported 53,900 shares stake. France-based Credit Agricole S A has invested 0.01% in Green Plains Inc (NASDAQ:GPRE). Sit Inv Assoc reported 42,875 shares stake. Goldman Sachs Group Incorporated has 255,449 shares for 0% of their portfolio. Bnp Paribas Arbitrage Sa reported 0% of its portfolio in Green Plains Inc (NASDAQ:GPRE).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com